Michael Greiner - 05 Mar 2024 Form 4 Insider Report for AVANOS MEDICAL, INC. (AVNS)

Role
SVP - Chief Financial Officer
Signature
/s/ Mojirade James, as attorney-in-fact for Michael C. Greiner
Issuer symbol
AVNS
Transactions as of
05 Mar 2024
Transactions value $
-$93,631
Form type
4
Filing time
06 Mar 2024, 16:10:24 UTC
Previous filing
09 May 2023
Next filing
07 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AVNS Common Stock Tax liability -$93.6K -4.99K -4.48% $18.76 106K 05 Mar 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects shares surrendered to the Issuer to satisfy tax withholding obligations upon the vesting of time-based restricted share units (TRSUs) awarded to the Reporting Person on March 4, 2022, of which 1/3 vested on March 4, 2023, 1/3 vested on March 4, 2024 and the remaining 1/3 will vest on March 4, 2025.